science
Hosted by Sean Khozin, MD, MPH · science · EN
Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside. All of them bring signal in a world crowded with noise.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
28%
Guest openness
Selective
Sign up to generate a grounded pitch for Precision Signals.
Signup to Generate a PitchPrecision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside.
Precision Signals is hosted by Sean Khozin, MD, MPH. The show has published 18 episodes to date.
Recent episodes include "Jedd D. Wolchok, MD, PhD: Curiosity, Conviction, and the Evolution of Cancer Immunotherapy" (14 October 2026, 67 minutes), "Peter Kolchinsky, PhD: Ideas That Refuse to Die" (27 August 2026, 101 minutes), and "Thomas Clozel, MD on Building Intelligence that Reads Life" (21 July 2026, 56 minutes).
Precision Signals publishes roughly monthly, with episodes averaging 64 minutes across 18 episodes.
Booking probability for Precision Signals is 28%, and the host is rated Selective on guests. Precision Signals requires a Pod Score of 80 or higher. Precision Signals's contact route on record: public web form.
The strongest fits for Precision Signals are Scientific Research & Development. Precision Signals has a science audience.
Sean Khozin, MD, MPH hosts Precision Signals, a science podcast with 18 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #17
In the late 1990s, much of oncology regarded cancer immunology as closer to mysticism than science. Jedd Wolchok, MD, PhD, was among the few who connected the early signals into a case that the immune system could...
In the latest episode of Precision Signals , Sean Khozin speaks with Peter Kolchinsky, founder and managing partner of RA Capital Management. Peter’s perspective is shaped in part by his experience as the child of...
<p>There is a sentence most physicians are trained never to say. Three words: I don't know. Thomas Clozel learned early — from Valentin Fuster at Mount Sinai — that those three words are not a confession of failure, but...
There is a sentence most physicians are trained never to say. Three words: I don't know. Thomas Clozel learned early — from Valentin Fuster at Mount Sinai — that those three words are not a confession of failure, but...
<p>Sahir Ali’s career defies conventional paths. Trained as an engineer, he worked in quantitative finance, contributed to cancer research, built software companies, and ultimately founded Modi Ventures, where he...
Sahir Ali’s career defies conventional paths. Trained as an engineer, he worked in quantitative finance, contributed to cancer research, built software companies, and ultimately founded Modi Ventures, where he developed...
<p>In this episode of Precision Signals, we speak with Mike Krzyzewski, known to most of the world as Coach K, about leadership, trust, teams, cancer advocacy, and the human side of progress.</p><p>Coach K is one of the...
<p>Dr. Brian Druker helped change the course of modern oncology through his central role in the development of imatinib (Gleevec), a therapy that transformed chronic myeloid leukemia (CML) and helped establish the...
<p>In this episode of Precision Signals, Sean Khozin, MD, MPH sits down with Clifford A. Hudis, MD, FACP, FASCO, CEO of the American Society of Clinical Oncology (ASCO), to trace a career that began with a childhood...
<p>Sunil Verma, SVP and Global Head of Oncology at AstraZeneca, has lived a life defined by reinvention. Born in Zambia, raised across Africa, India, and Canada, he was accepted to medical school at 19, became one of...
<p>As cancer treatments become more powerful and precise, the field of oncology is entering a new era. We are moving beyond the question of "Can we extend life?" to "How do we live with the biology these therapies...
<p>In this episode of Precision Signals, Sean Khozin sits down with Dr. David Fajgenbaum — physician, scientist, patient, and founder of Every Cure — to explore one of the most extraordinary stories in modern medicine...
<p>Most people know Sean Parker as the prodigy behind Napster and Facebook. Far fewer know why he chose to take on one of the hardest problems in science: cancer. In this clip from Precision Signals, we explore the...
<p>Sean Khozin in a conversation with Sushil (Sush) Patel, CEO of Replimune, discussing advancements in cancer immunotherapy, particularly the use of oncolytic viruses. They explore how engineered viruses can turn...
Episode #6
<p>In this episode of Precision Signals, Sean Khozin speaks with Dan McHugh, investor at Yosemite, about the systems that mediate between scientific discovery and patient impact. Dan’s path runs from Stanford...
Episode #5
<p>Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy (PICI), joins Dr. Sean Khozin to dissect the science and business of curing cancer. From her upbringing as a self-described "nomad" and "army...
Episode #4
<p>In Episode 4 of Precision Signals, Dr. Sean Khozin sits down with Daniel Arbess—investor, social entrepreneur, and healthcare innovator—to explore why the limiting factor in solving cancer and neurodegenerative...
<p>In this episode of Precision Signals, Dr. Sean Khozin speaks with Dr. James Gulley, Chief of the Medical Oncology Service and Co-Director of the Center for Immuno-Oncology at the National Cancer Institute.</p><p>Dr...
Episode #2
<p>Dr. Michelle Longmire, physician-scientist, technologist, and CEO, cofounder of Medable; shares how early lessons in science and systems design shaped her mission to fix one of medicine’s most persistent bottlenecks...
<p>What does it take for AI to move from technical innovation to real-world adoption in oncology?</p><p>In the first episode of Precision Signals, Dr. Sean Khozin speaks with Dr. Cora Sternberg and Dr. Olivier...
Recent guests on Precision Signals. Study who booked and why before you pitch.
Scientist, investor, author, founder of No Patient Left Behind, co-founder of RA Capital Management, RA Capital Management
Head Men's Basketball Coach, Duke University
Professor of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania
writer, artist, musician, cultural theorist, False Allegations Support Organization UK
PitchCentric classifies Precision Signals under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Bench to Boardroom
Talking Precision Medicine
Precision Medicine Podcast
BioSignals
Leaders in Life Sciences
Agilent “Dialogues in CDx” Podcast Series
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ